Literature DB >> 2813429

Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

D M Bodine1, S Karlsson, A W Nienhuis.   

Abstract

The effects of several hematopoietic growth factors on primitive murine bone marrow progenitor cells [colony-forming unit(s)-spleen (CFU-S)] have been investigated during culture for 2-6 days. Interleukin 3 (IL-3) was required for CFU-S survival in culture, and the combination of IL-3 and interleukin 6 (IL-6) increased the number of CFU-S in culture 10-fold over the number obtained with IL-3 alone. Stem cell function was measured by competitive repopulation; IL-3 was required, and IL-3 and IL-6 appear to act synergistically to enhance stem cell recovery from these cultures. These data appear to be relevant for retroviral-mediated gene transfer into stem and progenitor cells. Murine bone marrow cells were infected with a retrovirus containing the human beta-globin gene in the presence of various growth factors. Only 2 of 17 mice reconstituted with cells infected in the presence of IL-3 alone showed long-term expression of the human beta-globin gene (12 months), as opposed to 6 of 11 mice reconstituted with cells infected in the presence of IL-3 and IL-6. Medium conditioned by 5637 bladder carcinoma cells, a source of several hematopoietic growth factors, increased the frequency of infection of CFU-S but did not enhance stem cell infection or the repopulating potential of cultured bone marrow cells. Stem cells containing the human beta-globin provirus from these animals were shown to be capable of reconstituting secondary recipients in which the human beta-globin gene was expressed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813429      PMCID: PMC298397          DOI: 10.1073/pnas.86.22.8897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells.

Authors:  B Lim; J F Apperley; S H Orkin; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids.

Authors:  W C Forrester; S Takegawa; T Papayannopoulou; G Stamatoyannopoulos; M Groudine
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

3.  Stimulation of murine hemopoietic colony formation by human IL-6.

Authors:  G G Wong; J S Witek-Giannotti; P A Temple; R Kriz; C Ferenz; R M Hewick; S C Clark; K Ikebuchi; M Ogawa
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells.

Authors:  E A Dzierzak; T Papayannopoulou; R C Mulligan
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

6.  Effect of 5-fluorouracil on "primitive" hematopoietic stem cells that reconstitute whole erythropoiesis of genetically anemic W/Wv mice.

Authors:  T Nakano; N Waki; H Asai; Y Kitamura
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

7.  Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.

Authors:  C P Chiu; C Moulds; R L Coffman; D Rennick; F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice.

Authors:  S Karlsson; D M Bodine; L Perry; T Papayannopoulou; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

10.  Proliferation and differentiation of highly enriched mouse hematopoietic stem cells and progenitor cells in response to defined growth factors.

Authors:  C E Müller-Sieburg; K Townsend; I L Weissman; D Rennick
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  44 in total

Review 1.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

3.  Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability.

Authors:  C C Fraser; S J Szilvassy; C J Eaves; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions.

Authors:  A G Elefanty; S Cory
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

5.  Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation.

Authors:  S Ponnazhagan; P Mukherjee; X S Wang; K Qing; D M Kube; C Mah; C Kurpad; M C Yoder; E F Srour; A Srivastava
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Purification and characterization of retrovirally transduced hematopoietic stem cells.

Authors:  L M Spain; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

7.  Expression of a swine class II gene in murine bone marrow hematopoietic cells by retroviral-mediated gene transfer.

Authors:  G E Shafer; D W Emery; K Gustafsson; S Germana; W F Anderson; D H Sachs; C LeGuern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 8.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

9.  Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Authors:  R G Hawley; T S Hawley; A Z Fong; C Quinto; M Collins; J P Leonard; S J Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.

Authors:  C L Li; V J Dwarki; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.